血小板凝血酶受体抑制剂：它们会不负所望吗？ - Suppr | 超能文献

Inhibitors of the platelet thrombin receptor: will they live up to their promises?

作者信息

Van de Werf Frans

出版信息

Circulation. 2011 May 3;123(17):1833-5. doi: 10.1161/CIRCULATIONAHA.111.021733. Epub 2011 Apr 18.

DOI:10.1161/CIRCULATIONAHA.111.021733

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Inhibitors of the platelet thrombin receptor: will they live up to their promises?血小板凝血酶受体抑制剂：它们会不负所望吗？

Circulation. 2011 May 3;123(17):1833-5. doi: 10.1161/CIRCULATIONAHA.111.021733. Epub 2011 Apr 18.

2

Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.新型凝血酶诱导的血小板聚集和血栓形成抑制剂3-[2-[1,1':2',1"]-三联苯-4'-基)乙基]苯氧基乙酸的抗血栓作用

Arzneimittelforschung. 1997 Jan;47(1):13-8.

3

The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs.新型口服活性凝血酶受体拮抗剂 E5555（阿哌沙班）可抑制豚鼠动脉血栓形成而不影响出血时间。

Eur J Pharmacol. 2011 Apr 25;657(1-3):131-7. doi: 10.1016/j.ejphar.2011.01.058. Epub 2011 Feb 4.

4

Thrombin as a common downstream target blocking both platelet and monocyte activation.凝血酶作为一个共同的下游靶点，可阻断血小板和单核细胞的激活。

Thromb Haemost. 2009 Feb;101(2):220-1.

5

Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets.联合阻断凝血酶阴离子结合外显子-1 和 PAR4 可在人血小板中产生协同的抗血小板作用。

Thromb Haemost. 2011 Jan;105(1):88-95. doi: 10.1160/TH10-05-0305. Epub 2010 Nov 5.

6

Harnessing the platelet.利用血小板。

Am J Crit Care. 1997 Sep;6(5):406-14.

7

Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.用纤溶酶对人血小板进行预处理可抑制对凝血酶的反应，但会增强对低浓度聚集剂（包括凝血酶受体激活肽SFLLRN）的反应。

Thromb Haemost. 1997 Apr;77(4):741-7.

8

Antiplatelet drugs.抗血小板药物。

Br J Haematol. 2008 Aug;142(4):515-28. doi: 10.1111/j.1365-2141.2008.07233.x. Epub 2008 May 30.

9

Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.冠心病的抗血小板治疗。治疗和预防急性心肌梗死的新策略。

Arch Pathol Lab Med. 1993 Jan;117(1):89-96.

10

Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.氯吡格雷可减少择期冠状动脉导管插入术患者的包被血小板生成。

J Cardiovasc Pharmacol. 2008 Dec;52(6):536-9. doi: 10.1097/FJC.0b013e3181907390.

引用本文的文献

1

Activated platelets facilitate hematogenous metastasis of breast cancer by modulating the PDGFR-β/COX-2 axis.活化的血小板通过调节血小板衍生生长因子受体-β/环氧化酶-2轴促进乳腺癌的血行转移。

iScience. 2023 Aug 23;26(9):107704. doi: 10.1016/j.isci.2023.107704. eCollection 2023 Sep 15.

2

Platelet Subtypes in Inflammatory Settings.炎症环境中的血小板亚型

Front Cardiovasc Med. 2022 Apr 7;9:823549. doi: 10.3389/fcvm.2022.823549. eCollection 2022.